IFIH1 and dermatomyositis: Therefore, the present study was performed to identify the serological markers for anti-MDA5+ DM complicated with RP-ILD to assist in the achievement of a definitive diagnosis, accurate assessment of the patient’s condition, and improvement of the prognosis for patients with anti-MDA5+ DM.